Leef Brands (LEEEF) Convertible Debt (2024)
Leef Brands (LEEEF) posted Convertible Debt of $10.0 million for Q4 2024.
Leef Brands (LEEEF) Convertible Debt (2024) Analysis & Trends
Leef Brands has reported Convertible Debt for 1 years, with the latest figure at $10.0 million in Q4 2024.
- Quarterly Convertible Debt changed N/A year-over-year to $10.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $10.0 million (changed N/A YoY) and the FY2024 annual result came in at $10.0 million, changed N/A from the prior year.
- Convertible Debt steadied at $10.0 million in Q4 2024 per LEEEF's latest filing.
- Over five years, Convertible Debt peaked at $10.0 million in Q4 2024 and troughed at $10.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Leef Brands | 59.45 Mn | 54.50 Mn | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 9.98 Mn |